The present invention relates to compounds of the formula (I)
wherein R1 and R2 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, non-insulin dependent diabetes mellitus and/or impaired glucose tolerance, obesity, and/or metabolic syndrome or β-cell protection.
本发明涉及式(I)的化合物,其中R1和R2如描述和权利要求书所定义,并且其药学上可接受的盐。该化合物可用于治疗和/或预防与
DPP-IV相关的疾病,如糖尿病、非
胰岛素依赖性糖尿病和/或糖耐量受损、肥胖和/或代谢综合征或β细胞保护。